An experimental leishmaniasis vaccine relies on eliciting an immune response to a protein from the saliva of the sand fly that carries the leishmania parasite, rather than on anything from the parasite itself. Cynthia Graber reports
Learn more about your ad choices. Visit megaphone.fm/adchoices
